Comparison of COVID-19 survival in relation to CPAP length of treatment and by comorbidity and transmission setting (community or hospital acquired) in a medium-sized UK hospital in 2020: a retrospective study.
Luigi SeddaAbdul AshishAlison UnsworthJane MartindaleRamachandaran SundarMartin FarrierPublished in: BMJ open (2022)
The experience of an Acute Trust during the COVID-19 outbreak of 2020 is documented and indicates the importance of care home and hospitals in disease acquisition. Death rates fell between the first and second wave only for community-acquired COVID-19 patients. The fall was associated to CPAP length, especially for some comorbidities. While uncovering some risk and protective factors of mortality in COVID-19 studies, the study also unravels how little is known about PHA COVID-19 and the interaction between CPAP and some comorbidities.
Keyphrases
- healthcare
- sars cov
- coronavirus disease
- obstructive sleep apnea
- positive airway pressure
- sleep apnea
- mental health
- respiratory syndrome coronavirus
- liver failure
- respiratory failure
- cardiovascular disease
- acute care
- cardiovascular events
- adverse drug
- quality improvement
- emergency department
- chronic pain
- combination therapy
- smoking cessation